IBDEI0NS ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11709,1,1,0)
 ;;=1^710.1
 ;;^UTILITY(U,$J,358.3,11709,1,2,0)
 ;;=2^SYSTEMIC SCLEROSIS
 ;;^UTILITY(U,$J,358.3,11709,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,11710,0)
 ;;=446.7^^79^768^20
 ;;^UTILITY(U,$J,358.3,11710,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11710,1,1,0)
 ;;=1^446.7
 ;;^UTILITY(U,$J,358.3,11710,1,2,0)
 ;;=2^TAKAYASU'S DISEASE
 ;;^UTILITY(U,$J,358.3,11710,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,11711,0)
 ;;=446.6^^79^768^21
 ;;^UTILITY(U,$J,358.3,11711,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11711,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,11711,1,2,0)
 ;;=2^THROMBOT MICROANGIOPATHY
 ;;^UTILITY(U,$J,358.3,11711,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,11712,0)
 ;;=446.4^^79^768^22
 ;;^UTILITY(U,$J,358.3,11712,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11712,1,1,0)
 ;;=1^446.4
 ;;^UTILITY(U,$J,358.3,11712,1,2,0)
 ;;=2^WEGENER'S GRANULOMATOSIS
 ;;^UTILITY(U,$J,358.3,11712,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,11713,0)
 ;;=444.9^^79^768^9
 ;;^UTILITY(U,$J,358.3,11713,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11713,1,1,0)
 ;;=1^444.9
 ;;^UTILITY(U,$J,358.3,11713,1,2,0)
 ;;=2^OTH ARTERIAL EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,11713,2)
 ;;=^39452
 ;;^UTILITY(U,$J,358.3,11714,0)
 ;;=710.9^^79^768^10
 ;;^UTILITY(U,$J,358.3,11714,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11714,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,11714,1,2,0)
 ;;=2^OTH CONNECTIVE TISSUE DISEASE
 ;;^UTILITY(U,$J,358.3,11714,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,11715,0)
 ;;=453.9^^79^768^11
 ;;^UTILITY(U,$J,358.3,11715,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11715,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,11715,1,2,0)
 ;;=2^OTH VENOUS EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,11715,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,11716,0)
 ;;=441.00^^79^768^1
 ;;^UTILITY(U,$J,358.3,11716,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11716,1,1,0)
 ;;=1^441.00
 ;;^UTILITY(U,$J,358.3,11716,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION
 ;;^UTILITY(U,$J,358.3,11716,2)
 ;;=^35660
 ;;^UTILITY(U,$J,358.3,11717,0)
 ;;=042.^^79^769^1
 ;;^UTILITY(U,$J,358.3,11717,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11717,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,11717,1,2,0)
 ;;=2^AIDS OR HIV INFECTION
 ;;^UTILITY(U,$J,358.3,11717,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,11718,0)
 ;;=540.9^^79^769^2
 ;;^UTILITY(U,$J,358.3,11718,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11718,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,11718,1,2,0)
 ;;=2^APPENDICITIS
 ;;^UTILITY(U,$J,358.3,11718,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,11719,0)
 ;;=682.9^^79^769^3
 ;;^UTILITY(U,$J,358.3,11719,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11719,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,11719,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS
 ;;^UTILITY(U,$J,358.3,11719,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,11720,0)
 ;;=576.1^^79^769^4
 ;;^UTILITY(U,$J,358.3,11720,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11720,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,11720,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,11720,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,11721,0)
 ;;=574.70^^79^769^5
 ;;^UTILITY(U,$J,358.3,11721,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11721,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,11721,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,11721,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,11722,0)
 ;;=571.5^^79^769^6
 ;;^UTILITY(U,$J,358.3,11722,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11722,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,11722,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,11722,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,11723,0)
 ;;=323.9^^79^769^7
